• Mashup Score: 4
    Program Planner - 1 year(s) ago

    Program Planner One fine body�

    Tweet Tweets with this article
    • 🎤 Watch your favorite cardiologists & cardiac surgeons duke it out Family-Feud style as they prepare for the 2023 Cardiology #ACCCMP topic: #CHD. ⏰ Starts in 10 min in La Nouvelle C at #ACC23/#WCCardio! https://t.co/fAW8EsX3FM #ACCACPC #ACHD #ACCSurgeons #MOC https://t.co/DVtZBomDt8

  • Mashup Score: 0

    BOSTON — A novel mitral valve transcatheter edge-to-edge repair system was noninferior to an existing system in a head-to-head trial in patients with severe symptomatic degenerative mitral regurgitation, researchers reported at TCT 2022.For the CLASP IID trial, researchers compared the novel system (Pascal, Edwards Lifesciences) with the existing system (MitraClip, Abbott). As Healio

    Tweet Tweets with this article
    • “These efforts continue to push the envelope in terms of developing devices for treating patients,” Dr. Matthew A. Romano spoke with @CardiologyToday on the results of the CLASP IID trial presented at #TCT2022 & published in #JACCINT. https://t.co/5s2doVKGzT #ACCSurgeons #vhdMR

  • Mashup Score: 3

    The ACC’s Cardiac Surgery Team Member Section and Leadership Council is the home for all members of the cardiac surgery heart team within the ACC, advocating for and advancing the priorities of the community.

    Tweet Tweets with this article
    • While you're waiting for the next #AHA21 session, "Valves, Veins and New Viewpoints in Cardiothoracic Surgery," find helpful resources for the entire 💗 surgery team on the ACC's Cardiac Surgery Team Section page. Check it out here 🔎 https://t.co/wYgvllcZ34 #ACCSurgeons #cvSurg https://t.co/xftzFbLRq8

  • Mashup Score: 4

    I suspect many of us have grown weary of hearing about what ISCHEMIA, COURAGE, those fractional flow reserve (FFR) trials, and CIAO (see below if that trial escaped you) tell us about best therapeutic strategies for coronary artery disease (CAD). That is not what this editorial is about. As I think about these trials, I can’t rid myself of some…

    Tweet Tweets with this article
    • In the latest issue of #CardiologyMag, Dr. Peter Block (@pblockemoryedu1) explains why we need to change our standard thinking about #cvCAD. Learn more here: https://t.co/r7plpK8gAl #ACCIC #ACCSurgeons https://t.co/rpvNHImNk7